CRISPR/Cas9 genome-edited universal CAR T cells in patients with relapsed/refractory lymphoma.
作者信息
Guo Yelei, Tong Chuan, Su Liping, Zhang Wenying, Jia Hejin, Liu Yang, Yang Qingming, Wu Zhiqiang, Wang Yao, Han Weidong
机构信息
Department of Bio-therapeutics, First Medical Centre, Chinese PLA General Hospital, Beijing, China.
Department of Hematology, Shanxi Cancer Hospital, Shanxi, China; and.
出版信息
Blood Adv. 2022 Apr 26;6(8):2695-2699. doi: 10.1182/bloodadvances.2021006232.
Abstract
摘要
Zotero 插件